Institut suisse de recherche expérimentale sur le cancer ‐ EPFL

L’intégration de la recherche fondamentale et translationnelle sur le cancer à la biologie fondamentale cellullaire et développementale.

Biologie cellulaire et moléculaire du développement et du cancer

Recherche fondamentale et translationnelle sur le cancer

OPEN POSITION: Faculty Position in Interdisciplinary Cancer Research (deadline: January 8, 2021)

A screenshot of MarrowQuant annotating a bone marrow trephine biopsy from a patient surfing from chemotherapy-induced aplasia. Credit: Olaia Naveiras (EPFL)

MarrowQuant: a digital-pathology tool

Published:29.09.20 — EPFL scientists have developed a digital pathology workflow for quantifying bone marrow compartments in standard histological sections. Named “MarrowQuant”, this workflow based on the open source software QuPath makes it possible to examine bone marrow biopsies as well as to re-examine historical collections of bone-marrow samples and even old clinical trials.

The “G” represents the highly expressed glucose transporters Glut1 and Glut3 in lung adenocarcinomas. Left: the dual deletion impairing lung tumor growth. Credit: Liloon (Julie de Meyer)

Blocking sugar metabolism slows lung tumour growth

Published:23.06.20 — Treatments that block two sugar-transporting proteins could help slow the growth of lung tumours, new research from EPFL suggests.

How accurate are transcription factor binding-site motifs?

Published:12.06.20 — An international team led by researchers from EPFL and the Russian Academy of Sciences have undertaken a comprehensive benchmarking study to assess the predictive performance of publicly available transcription factor binding site motifs.

Toutes les actualités